NIH glucosamine/chondroitin study
This article was originally published in The Tan Sheet
Executive Summary
Contract for the trial is expected to be awarded by the end of the government's fiscal year Sept. 31. To be sponsored jointly by the NIH National Center for Complementary & Alternative Medicine and the National Institute of Arthritis & Musculoskeletal & Skin Disease, the study will evaluate glucosamine alone and in combination with chondroitin for pain management in subjects with osteoarthritis